Dart NeuroScience, LLC Report issue

For profit Phase 2
Founded: San Diego CA United States (2008)
Status: Defunct (2017)

Organization Overview

First Clinical Trial
2008
NCT00758446
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Dart NeuroScience, LLC

Active Ingredients

Drugs in Phase 2 Trials (6)

blx-028914 (1 trial)

dns-3379 (1 trial)

dns-7801 (1 trial)

ht-0712 (2 trials)

ht-2157 (1 trial)

ht-3951 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Depression (Phase 2)

Depressive Disorder (Phase 2)

Depressive Disorder, Major (Phase 2)

Ischemia (Phase 2)

Memory Disorders (Phase 2)

Parkinson Disease (Phase 2)

Rhinitis (Phase 2)

Rhinitis, Allergic (Phase 2)

Stroke (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 7
  • # of Trial APIs: 6